ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 723531 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 723531; 2) Community: the network communities that were significantly associated with the response to NSC 723531; 3) Molecule: the relationships between components within communities and NSC 723531; 4) MDR: the compounds that were significantly associated with the NSC 723531.

NSC Compound Enrichment Correlation
NSC 740520 6-(3-Bromopropyl)-9-fluoro-5,6-dihydro-2,3-dimethoxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.000127064839447042 0.14376734
NSC 664161 Null 0.000190877555957481 0.16460822
NSC 751620 Null 0.00101750714202618 0.0094511298
NSC 760289 3-hydroxy-8,9-dimethoxy-isoindolo[2,1a]quinoxalin-6-(5H)-imino 0.00101750714202618 -0.0051699373
NSC 691251 Null 0.00107480559257738 0.14963916
NSC 58905 9H-Purine, 9-(2-chloroethyl)-6-[(phenylmethyl)thio]- (9CI) 0.00109467026514912 0.063106302
NSC 680418 Null 0.00109467026514912 0.18138548
NSC 697539 6-Amino-3-chloromethyl-1-((5-(((benzofuran-2-yl)-carbonyl)amino)indol-2-ylcarbonyl)indoline 0.00109467026514912 0.29930428
NSC 639174 Camptothecin Derivative 0.00112942993514741 0.13854513
NSC 659950 7-O-(3,4-Di-O-acetyl-2,3,6-trideoxy-2-fluoro-.alpha.-L-talo-hexopyranosyl)-4-demethoxydaunomycinone 0.00112942993514741 0.23606926
Total:46  Current:1    [First] [Prev] [Next] [Last]